framycetin has been researched along with Atresia, Biliary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, LN; Chang, MH; Chen, AC; Chen, HL; Hsu, HY; Lai, MW; Lee, IH; Lien, TH; Ni, YH; Shih, HH; Wu, JF | 1 |
| Bu, LN; Chang, CJ; Chang, MH; Chen, HL; Hsu, HY; Hsu, WM; Lai, HS; Ni, YH | 1 |
| DeFelice, AR; Mones, RL; Preud'Homme, D | 1 |
2 trial(s) available for framycetin and Atresia, Biliary
| Article | Year |
|---|---|
Use of Lactobacillus casei rhamnosus to Prevent Cholangitis in Biliary Atresia After Kasai Operation.
Topics: Anti-Bacterial Agents; Biliary Atresia; Body Weight; Cholangitis; Disease-Free Survival; Escherichia coli; Feces; Female; Humans; Infant; Infant, Newborn; Lacticaseibacillus casei; Lacticaseibacillus rhamnosus; Lactobacillus; Male; Neomycin; Pilot Projects; Portoenterostomy, Hepatic; Probiotics; Recurrence | 2015 |
Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy.
Topics: Antibiotic Prophylaxis; Biliary Atresia; Child, Preschool; Cholangitis; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Life Tables; Male; Neomycin; Portoenterostomy, Hepatic; Postoperative Complications; Prospective Studies; Recurrence; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
1 other study(ies) available for framycetin and Atresia, Biliary
| Article | Year |
|---|---|
Use of neomycin as the prophylaxis against recurrent cholangitis after Kasai portoenterostomy.
Topics: Administration, Oral; Biliary Atresia; Cholangitis; Female; Humans; Infant, Newborn; Neomycin; Portoenterostomy, Hepatic; Postoperative Complications; Prognosis; Recurrence; Time Factors | 1994 |